Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2025-12-26 @ 1:39 AM
NCT ID:
NCT00790933
Group ID:
EG000
Title:
Vedolizumab 300 mg
Description:
Vedolizumab 300 mg, 30-minute IV infusion, Q4W, up to approximately 260 weeks. Includes De Novo participants and participants previously enrolled in studies C13004, C13006, C13007 and C13011.
Deaths Number Affected:
10
Deaths Number At Risk:
None
Serious Number Affected:
825
Serious Number At Risk:
2243
Other Number Affected:
1820
Other Number At Risk:
2243
Study:
NCT00790933
Results Section:
NCT00790933
Adverse Events Module:
NCT00790933